Oncocorner

Online Course
on demand

May
2022

Telemedicine in Cancer Care Continuum: implementation and integration

BACKGROUND

Telemedicine promises to revolutionize care pathways for cancer patients as modern health systems design and conceptualize new ways to manage the entire Cancer Care Continuum, moving from hospital-centered models of care to a patient-centered, proximity-based approach to care. The fundamental concept is that information and data move, not patients. Prior to Covid-19, the world had experienced an uneven spread of digital health practices in its various applications, ranging from telemedicine to mobile health.

Prior to Covid-19, the world was experiencing an uneven spread of digital health practices, ranging from telemedicine to mobile health. The pandemic has undoubtedly produced an acceleration in the adoption of digital technologies, pushing regions and countries to consolidate projects already in the pipeline, or to move towards a first experience in the application of telemedicine to diagnosis, treatment and care, to limit waiting times and physical contact.

In this perspective, in collaboration with ASCO (American Society in Clinical Oncology), SPCC has launched the first phase of the Telemedicine in Cancer Care in 2021 project. The aim is to promote the topic of telemedicine from the state of the art and its tele-applications around the world, its potential, limitations, barriers and challenges, to the exploration of new frontiers.

The second phase of the project will focus on how to overcome both barriers and limitations, addressing new challenges through the sharing of best practices on telemedicine applications in the cancer care continuum. The goal is to create the best conditions to implement and integrate telemedicine applications to truly and effectively improve the cancer care pathway, first of all for patients and their relatives, but also for health systems, in terms of cost-effectiveness, efficiency and sustainability.

CONFERENCE GOALS

- To focus on the implementation and integration of telemedicine in the Cancer Care Continuum (e.g., critical success factors, technical barriers and organizational and legal issues)

- To enhance cooperation between clinicians, HCPs and management (integrated and interconnected care team)

- To share patient’s perspective and implications in telemedicine

- To show the best practice experiences at regional/national level

TARGET GROUP

HCPs - Cancer Patients Organisations- Oncologists - Researchers - Medical Companies - Cancer Institutes – Academia - Healthcare Public Authorities - Regulatory and Policy Bodies - Technological institutes

CONFERENCE FORMAT

The conference will be held online with the participation of world-renowned experts, some of them already involved in the 2021 "SPCC Telemedicine in Cancer Care Project".

It will be free of charge and can be accessed by registering on SPCC's OncoCorner e-learning platform.

The material will remain available on-demand.

CONFERENCE CONTENT

The event will consist of 2 consecutive days of live sessions with recorded and live contributions.

Faculty, programme and further information on the course will be available soon.

CME ACCREDITATION AND CERTIFICATES

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email.

Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 4 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

REGISTRATION

Event attendance will be free of charge, but registration is required.

ACKNOWLEDGEMENTS

Sharing Progress in Cancer Care wishes to express its appreciation to AstraZeneca, Eisai and Pfizer for having granted their support to the Conference.

06/05/2022 14:30 CEST